Clinical trial
Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women…
NCT00335894 · IBSA Institut Biochimique SA, Industry · Completed
Key facts
| NCT number | NCT00335894 |
|---|---|
| Title | Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF). |
| Official title | A Prospective, Randomized, Investigator-blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) vs Menopur (Ferring) Administered s.c. in Women Undergoing COH in an ART Programme (IVF) |
| Lead sponsor | IBSA Institut Biochimique SA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug |
| Interventions | hMG-IBSA |
| Enrollment | 144 |
| Start date | May 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Jun 12, 2006 |
| Last update posted | Mar 10, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: